文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

院前乳酸清除率与脓毒性休克患者死亡率降低相关

Prehospital lactate clearance is associated with reduced mortality in patients with septic shock.
PubMed 文献 · Am J Emerg Med · 2020-10-17
一句话结论脓毒性休克患者院前乳酸清除率<10%与30天死亡率升高独立相关(HRa 2.04),>10%与死亡率降低相关(HRa 0.49)。

这项前瞻性观察研究纳入2017年4月15日至2019年4月15日期间需要院前移动ICU干预的脓毒性休克患者185例,其中175例(95%)可分析院前血乳酸清除率(平均年龄70±14岁)。30天总死亡率为32%。死亡患者与存活患者的平均院前血乳酸清除率分别为0.41±2.50 mmol/l与1.65±2.88 mmol/l(p=0.007)。Cox回归显示,30天死亡率与院前血乳酸清除率>10%(HRa 0.49,95%CI 0.26-0.92,p=0.028)及<10%(HRa 2.04,95%CI 1.08-3.84,p=0.028)相关。作者认为,院前乳酸清除率<10%与脓毒性休克患者30天死亡率升高相关,尚需进一步研究评估其单独或联合临床评分对分诊决策的影响。

要点

  • 脓毒性休克患者院前乳酸清除率<10%与30天死亡率升高独立相关(HRa 2.04,95%CI 1.08-3.84,p=0.028)。
  • 院前乳酸清除率>10%与30天死亡率降低独立相关(HRa 0.49,95%CI 0.26-0.92,p=0.028)。
  • 死亡患者院前乳酸清除率为0.41±2.50 mmol/l,存活患者为1.65±2.88 mmol/l,差异有统计学意义(p=0.007)。
  • 175例可分析患者中30天总死亡率为32%,感染来源以肺部(56%)、消化道(22%)和泌尿道(10%)为主。
  • 院前乳酸清除率按首次接触时(任何治疗前)与入院时血乳酸差值除以院前血乳酸计算。

适用人群与场景

  • 2017年4月15日至2019年4月15日期间需要院前移动ICU干预的脓毒性休克患者,前瞻性纳入185例,175例(95%)可分析院前血乳酸清除率,平均年龄70±14岁。

诊断标准与关键阈值

  • 院前血乳酸清除率=(院前血乳酸-入院时血乳酸)/院前血乳酸,院前血乳酸于患者与移动ICU首次接触时、任何治疗前测定,入院血乳酸于入院时测定。
  • 院前血乳酸清除率阈值10%:>10%与30天死亡率降低相关(HRa 0.49),<10%与30天死亡率升高相关(HRa 2.04)。

研究设计与关键结果

  • 前瞻性观察性研究纳入185例脓毒性休克患者,院前乳酸测量缺失6例(3%)、入院乳酸测量缺失4例(2%),175例(95%)分析院前血乳酸清除率。
  • 感染可能来源:肺部56%、消化道22%、泌尿道10%。
  • 30天总死亡率为32%。
  • 死亡患者院前血乳酸清除率0.41±2.50 mmol/l vs 存活患者1.65±2.88 mmol/l,p=0.007。
  • Cox回归:院前血乳酸清除率>10%与30天死亡率相关(HRa 0.49,95%CI 0.26-0.92,p=0.028);院前血乳酸清除率<10%与30天死亡率相关(HRa 2.04,95%CI 1.08-3.84,p=0.028)。

证据类型、等级与局限

  • 证据类型:前瞻性观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,院前血乳酸清除率<10%与脓毒性休克患者30天死亡率升高相关。
  • 作者认为,尚需进一步研究评估院前血乳酸清除率单独或联合临床评分是否可影响此类患者的分诊决策过程。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Assessment of disease severity in patients with septic shock (SS) is crucial in determining optimal level of care. In both pre- and in-hospital settings, blood lactate measurement is broadly used in combination with the clinical evaluation of patients as the clinical picture alone is not sufficient for assessing disease severity and outcomes.

METHODS: From 15th April 2017 to 15th April 2019, patients with SS requiring prehospital mobile Intensive Care Unit intervention (mICU) were prospectively included in this observational study. Prehospital blood lactate clearance was estimated by the difference between prehospital (time of first contact between the patients and the mICU prior to any treatment) and in-hospital (at hospital admission) blood lactate levels divided by prehospital blood lactate.

RESULTS: Among the 185 patients included in this study, lactate measurement was missing for six (3%) in the prehospital setting and for four (2%) at hospital admission, thus 175 (95%) were analysed for prehospital blood lactate clearance (mean age 70 ± 14 years). Pulmonary, digestive and urinary infections were probably the cause of the SS in respectively 56%, 22% and 10% of the cases. The 30-day overall mortality was 32%. Mean prehospital blood lactate clearance was significantly different between patients who died and those who survived (respectively 0.41 ± 2.50 mmol.l-1 vs 1.65 ± 2.88 mmol.l-1, p = 0.007). Cox regression analysis showed that 30-day mortality was associated with prehospital blood lactate clearance > 10% (HRa [CI95] = 0.49 [0.26-0.92], p = 0.028) and prehospital blood lactate clearance < 10% (HRa [CI95] = 2.04 [1.08-3.84], p = 0.028).

CONCLUSION: A prehospital blood lactate clearance < 10% is associated with 30-day mortality increase in patients with SS handled by the prehospital mICU. Further studies will be needed to evaluate if prehospital blood lactate clearance alone or combined with clinical scores could affected the triage decision-making process for those patients.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Jouffroy R, Léguillier T, Gilbert B, et al. Prehospital lactate clearance is associated with reduced mortality in patients with septic shock. Am J Emerg Med. 2020. PMID: 33097320. doi:10.1016/j.ajem.2020.10.018

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。